Literature DB >> 26609123

Cardiorenal syndrome: review of our current understanding.

Savvas Hadjiphilippou1, Sui Phin Kon2.   

Abstract

Renal and cardiac diseases are both prevalent and carry significant morbidity and mortality. They share common vascular risk factors and are physiologically interlinked. Dysfunction in one organ affects the other. Concurrent renal and cardiac disease is associated with a poor prognosis. This close relationship is reflected through cardiorenal syndrome. A classification system has been proposed; however, the underlying process is complex and multifactorial. Management of this syndrome focuses on improving heart function, reducing volume overload, and managing heart failure and chronic kidney disease. This, however, is challenging, limited by paucity of evidence and may lead to suboptimal therapy. Increased recognition of this syndrome should raise awareness in providing early therapy and avoiding adverse outcomes due to under-treatment. In this article, we provide an overview of our current understanding of cardiorenal syndrome, as well as its pathophysiology and treatment options. © The Royal Society of Medicine.

Entities:  

Keywords:  Heart failure; acute kidney injury; cardiorenal syndrome; chronic kidney disease; pathophysiology

Mesh:

Year:  2015        PMID: 26609123      PMCID: PMC4724773          DOI: 10.1177/0141076815616091

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


  30 in total

1.  Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure.

Authors:  Daniel E Forman; Javed Butler; Yongfei Wang; William T Abraham; Christopher M O'Connor; Stephen S Gottlieb; Evan Loh; Barry M Massie; Michael W Rich; Lynne Warner Stevenson; James B Young; Harlan M Krumholz
Journal:  J Am Coll Cardiol       Date:  2004-01-07       Impact factor: 24.094

2.  The influence of venous pressure on the isolated mammalian kidney.

Authors:  F R Winton
Journal:  J Physiol       Date:  1931-06-06       Impact factor: 5.182

3.  Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial.

Authors:  Bradley A Bart; Andrew Boyle; Alan J Bank; Inder Anand; Maria Teresa Olivari; Mark Kraemer; Shari Mackedanz; Paul A Sobotka; Mike Schollmeyer; Steven R Goldsmith
Journal:  J Am Coll Cardiol       Date:  2005-11-04       Impact factor: 24.094

Review 4.  Chronic kidney disease and mortality risk: a systematic review.

Authors:  Marcello Tonelli; Natasha Wiebe; Bruce Culleton; Andrew House; Chris Rabbat; Mei Fok; Finlay McAlister; Amit X Garg
Journal:  J Am Soc Nephrol       Date:  2006-05-31       Impact factor: 10.121

5.  Neuropeptide Y-induced acceleration of postangioplasty occlusion of rat carotid artery.

Authors:  Lijun Li; Edward W Lee; Hong Ji; Zofia Zukowska
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-04-10       Impact factor: 8.311

6.  Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial.

Authors:  Michael S Cuffe; Robert M Califf; Kirkwood F Adams; Raymond Benza; Robert Bourge; Wilson S Colucci; Barry M Massie; Christopher M O'Connor; Ileana Pina; Rebecca Quigg; Marc A Silver; Mihai Gheorghiade
Journal:  JAMA       Date:  2002-03-27       Impact factor: 56.272

7.  Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).

Authors:  Kirkwood F Adams; Gregg C Fonarow; Charles L Emerman; Thierry H LeJemtel; Maria Rosa Costanzo; William T Abraham; Robert L Berkowitz; Marie Galvao; Darlene P Horton
Journal:  Am Heart J       Date:  2005-02       Impact factor: 4.749

8.  Reactive oxygen species mediate alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes.

Authors:  J K Amin; L Xiao; D R Pimental; P J Pagano; K Singh; D B Sawyer; W S Colucci
Journal:  J Mol Cell Cardiol       Date:  2001-01       Impact factor: 5.000

9.  Use of dopamine in acute renal failure: a meta-analysis.

Authors:  J A Kellum; J M Decker
Journal:  Crit Care Med       Date:  2001-08       Impact factor: 7.598

Review 10.  The role of peritoneal dialysis in the management of treatment-resistant congestive heart failure: A European perspective.

Authors:  N Khalifeh; A Vychytil; W H Hörl
Journal:  Kidney Int Suppl       Date:  2006-11       Impact factor: 10.545

View more
  4 in total

Review 1.  Beyond the Cardiorenal Syndrome: Pathophysiological Approaches and Biomarkers for Renal and Cardiac Crosstalk.

Authors:  Oana Nicoleta Buliga-Finis; Anca Ouatu; Minerva Codruta Badescu; Nicoleta Dima; Daniela Maria Tanase; Patricia Richter; Ciprian Rezus
Journal:  Diagnostics (Basel)       Date:  2022-03-22

Review 2.  Heart failure and kidney dysfunction: epidemiology, mechanisms and management.

Authors:  Joerg C Schefold; Gerasimos Filippatos; Gerd Hasenfuss; Stefan D Anker; Stephan von Haehling
Journal:  Nat Rev Nephrol       Date:  2016-08-30       Impact factor: 28.314

3.  Dilatation of the aorta in children with advanced chronic kidney disease.

Authors:  Sophie Quennelle; Caroline Ovaert; Mathilde Cailliez; Florentine Garaix; Michel Tsimaratos; Fedoua El Louali
Journal:  Pediatr Nephrol       Date:  2021-01-18       Impact factor: 3.714

4.  Establishment and assessment of a nomogram model for predicting the risk of fulminant myocarditis: A STROBE compliant cross-sectional study.

Authors:  Guifen Xu; Feizhen Chen; Wenxiang Zhao; Yong Zheng; Wei Zhuang; Fuling Yu
Journal:  Medicine (Baltimore)       Date:  2021-04-30       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.